![](/img/cover-not-exists.png)
PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA
Al Jedai, A., AL-Mudaiheem, H., Aldail, M., Fatani, M., Binamer, Y., Sharma, Y., Mohamed, O., Awad, N., Al-Amaa, T.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.086
Date:
May, 2020
File:
PDF, 383 KB
2020